Can I read OPDIVO Infusion: Usage and Guidelines on EtoBox?

OPDIVO Infusion: Usage and Guidelines by Laurentiu Decu is a document available to read on EtoBox.

What is OPDIVO Infusion: Usage and Guidelines about?

This document provides the product characteristics for OPDIVO (nivolumab), including information on its composition, approved therapeutic indications, posology, special warnings, and other clinical particulars. It summarizes that OPDIVO is approved as a monotherapy or in combination with ipilimumab for the treatment of advanced melanoma, NSCLC, and RCC in adults. Dosing is typically 3 mg/kg every 2 weeks as a monotherapy or 1 mg/kg every 3 weeks in combination with ipilimumab, with treatment continuing as l

Author

Laurentiu Decu

Language

EN